US Stock MarketDetailed Quotes

TCRR TCR2 Therapeutics

Watchlist
  • 1.480
  • 0.0000.00%
Close Jun 2 09:30 ET
58.11MMarket Cap-352P/E (TTM)

TCR2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.82%37.47M
28.10%123.08M
29.42%31.01M
18.53%31.1M
30.78%31.77M
32.64%28.64M
39.86%96.08M
29.02%23.96M
52.64%26.24M
45.33%24.29M
Selling and administrative expenses
29.76%8.2M
8.60%24.44M
11.47%5.8M
5.85%6.31M
5.97%6M
11.50%6.32M
34.59%22.5M
21.95%5.21M
36.42%5.96M
48.75%5.67M
-General and administrative expense
29.76%8.2M
8.60%24.44M
11.47%5.8M
5.85%6.31M
5.97%6M
11.50%6.32M
34.59%22.5M
21.95%5.21M
36.42%5.96M
48.75%5.67M
Research and development costs
31.12%29.27M
34.07%98.64M
34.41%25.2M
22.26%24.79M
38.33%25.77M
40.17%22.32M
41.55%73.58M
31.14%18.75M
58.17%20.28M
44.32%18.63M
Operating profit
-30.82%-37.47M
-28.10%-123.08M
-29.42%-31.01M
-18.53%-31.1M
-30.78%-31.77M
-32.64%-28.64M
-39.86%-96.08M
-29.02%-23.96M
-52.64%-26.24M
-45.33%-24.29M
Net non-operating interest income expense
849.57%1.11M
765.18%1.94M
2,565.79%1.01M
1,242.11%510K
831.25%298K
0.86%117K
-87.10%224K
-80.10%38K
-87.33%38K
-93.59%32K
Non-operating interest income
849.57%1.11M
765.18%1.94M
2,565.79%1.01M
1,242.11%510K
831.25%298K
0.86%117K
-87.10%224K
-80.10%38K
-87.33%38K
--32K
Other net income (expense)
-617.76%-4.04M
-730.84%-30.42M
-563K
-3.66M
Special income (charges)
-617.76%-4.04M
-730.84%-30.42M
----
----
----
---563K
---3.66M
----
----
----
-Write off
617.76%4.04M
730.84%30.42M
----
----
----
--563K
--3.66M
----
----
----
Income before tax
-38.88%-40.4M
-52.30%-151.56M
-119.04%-60.41M
-16.76%-30.59M
-29.73%-31.47M
-35.43%-29.09M
-48.62%-99.52M
-50.08%-27.58M
-55.12%-26.2M
-49.60%-24.26M
Income tax
-91.67%3K
-9.69%261K
-40.00%96K
-97.62%1K
150.98%128K
0.00%36K
79.50%289K
113.33%160K
35.48%42K
82.14%51K
Net income
-38.72%-40.4M
-52.12%-151.82M
-118.12%-60.51M
-16.58%-30.59M
-29.98%-31.6M
-35.38%-29.12M
-48.69%-99.81M
-50.34%-27.74M
-55.09%-26.24M
-49.66%-24.31M
Net income continuous Operations
-38.72%-40.4M
-52.12%-151.82M
-118.12%-60.51M
-16.58%-30.59M
-29.98%-31.6M
-35.38%-29.12M
-48.69%-99.81M
-50.34%-27.74M
-55.09%-26.24M
-49.66%-24.31M
Minority interest income
Net income attributable to the parent company
-38.72%-40.4M
-52.12%-151.82M
-118.12%-60.51M
-16.58%-30.59M
-29.98%-31.6M
-35.38%-29.12M
-48.69%-99.81M
-50.34%-27.74M
-55.09%-26.24M
-49.66%-24.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.72%-40.4M
-52.12%-151.82M
-118.12%-60.51M
-16.58%-30.59M
-29.98%-31.6M
-35.38%-29.12M
-48.69%-99.81M
-50.34%-27.74M
-55.09%-26.24M
-49.66%-24.31M
Basic earnings per share
-35.53%-1.03
-49.43%-3.93
-116.67%-1.56
-14.49%-0.79
-28.13%-0.82
-31.03%-0.76
-9.58%-2.63
-30.91%-0.72
-23.21%-0.69
4.48%-0.64
Diluted earnings per share
-35.53%-1.03
-49.43%-3.93
-116.67%-1.56
-14.49%-0.79
-28.13%-0.82
-31.03%-0.76
-9.58%-2.63
-30.91%-0.72
-23.21%-0.69
4.48%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.82%37.47M28.10%123.08M29.42%31.01M18.53%31.1M30.78%31.77M32.64%28.64M39.86%96.08M29.02%23.96M52.64%26.24M45.33%24.29M
Selling and administrative expenses 29.76%8.2M8.60%24.44M11.47%5.8M5.85%6.31M5.97%6M11.50%6.32M34.59%22.5M21.95%5.21M36.42%5.96M48.75%5.67M
-General and administrative expense 29.76%8.2M8.60%24.44M11.47%5.8M5.85%6.31M5.97%6M11.50%6.32M34.59%22.5M21.95%5.21M36.42%5.96M48.75%5.67M
Research and development costs 31.12%29.27M34.07%98.64M34.41%25.2M22.26%24.79M38.33%25.77M40.17%22.32M41.55%73.58M31.14%18.75M58.17%20.28M44.32%18.63M
Operating profit -30.82%-37.47M-28.10%-123.08M-29.42%-31.01M-18.53%-31.1M-30.78%-31.77M-32.64%-28.64M-39.86%-96.08M-29.02%-23.96M-52.64%-26.24M-45.33%-24.29M
Net non-operating interest income expense 849.57%1.11M765.18%1.94M2,565.79%1.01M1,242.11%510K831.25%298K0.86%117K-87.10%224K-80.10%38K-87.33%38K-93.59%32K
Non-operating interest income 849.57%1.11M765.18%1.94M2,565.79%1.01M1,242.11%510K831.25%298K0.86%117K-87.10%224K-80.10%38K-87.33%38K--32K
Other net income (expense) -617.76%-4.04M-730.84%-30.42M-563K-3.66M
Special income (charges) -617.76%-4.04M-730.84%-30.42M---------------563K---3.66M------------
-Write off 617.76%4.04M730.84%30.42M--------------563K--3.66M------------
Income before tax -38.88%-40.4M-52.30%-151.56M-119.04%-60.41M-16.76%-30.59M-29.73%-31.47M-35.43%-29.09M-48.62%-99.52M-50.08%-27.58M-55.12%-26.2M-49.60%-24.26M
Income tax -91.67%3K-9.69%261K-40.00%96K-97.62%1K150.98%128K0.00%36K79.50%289K113.33%160K35.48%42K82.14%51K
Net income -38.72%-40.4M-52.12%-151.82M-118.12%-60.51M-16.58%-30.59M-29.98%-31.6M-35.38%-29.12M-48.69%-99.81M-50.34%-27.74M-55.09%-26.24M-49.66%-24.31M
Net income continuous Operations -38.72%-40.4M-52.12%-151.82M-118.12%-60.51M-16.58%-30.59M-29.98%-31.6M-35.38%-29.12M-48.69%-99.81M-50.34%-27.74M-55.09%-26.24M-49.66%-24.31M
Minority interest income
Net income attributable to the parent company -38.72%-40.4M-52.12%-151.82M-118.12%-60.51M-16.58%-30.59M-29.98%-31.6M-35.38%-29.12M-48.69%-99.81M-50.34%-27.74M-55.09%-26.24M-49.66%-24.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.72%-40.4M-52.12%-151.82M-118.12%-60.51M-16.58%-30.59M-29.98%-31.6M-35.38%-29.12M-48.69%-99.81M-50.34%-27.74M-55.09%-26.24M-49.66%-24.31M
Basic earnings per share -35.53%-1.03-49.43%-3.93-116.67%-1.56-14.49%-0.79-28.13%-0.82-31.03%-0.76-9.58%-2.63-30.91%-0.72-23.21%-0.694.48%-0.64
Diluted earnings per share -35.53%-1.03-49.43%-3.93-116.67%-1.56-14.49%-0.79-28.13%-0.82-31.03%-0.76-9.58%-2.63-30.91%-0.72-23.21%-0.694.48%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg